HighPoint Advisor Group’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.07M | Buy |
2,946
+460
| +19% | +$157K | 0.04% | 308 |
|
|
2026
Q1 | $875K | Sell |
2,486
-11,807
| -83% | -$4.21M | 0.04% | 315 |
|
|
2025
Q4 | $4.68M | Buy |
14,293
+2,362
| +20% | +$749K | 0.1% | 179 |
|
|
2025
Q3 | $3.37M | Buy |
11,931
+72
| +0.6% | +$20.9K | 0.16% | 107 |
|
|
2025
Q2 | $3.31M | Buy |
11,859
+262
| +2% | +$74.2K | 0.18% | 104 |
|
|
2025
Q1 | $3.35M | Sell |
11,597
-693
| -6% | -$205K | 0.19% | 95 |
|
|
2024
Q4 | $3.63M | Sell |
12,290
-321
| -3% | -$95.2K | 0.2% | 90 |
|
|
2024
Q3 | $4.06M | Buy |
12,611
+106
| +0.8% | +$34.7K | 0.24% | 71 |
|
|
2024
Q2 | $4.17M | Buy |
12,505
+1,248
| +11% | +$367K | 0.25% | 72 |
|
|
2024
Q1 | $3.47M | Buy |
11,257
+333
| +3% | +$97.4K | 0.25% | 71 |
|
|
2023
Q4 | $3.07M | Buy |
+10,924
| New | +$2.98M | 0.22% | 83 |
|
|
2022
Q2 | $2.74M | Buy |
+11,155
| New | +$2.73M | 0.3% | 65 |
|
|
2021
Q3 | $3.01M | Buy |
14,164
+654
| +5% | +$151K | 0.3% | 69 |
|
|
2021
Q2 | $3.29M | Buy |
13,510
+1,059
| +9% | +$261K | 0.33% | 62 |
|
|
2021
Q1 | $3.1M | Sell |
12,451
-197
| -2% | -$47K | 0.36% | 60 |
|
|
2020
Q4 | $2.99M | Buy |
12,648
+7,747
| +158% | +$1.79M | 0.36% | 60 |
|
|
2020
Q3 | $1.14M | Sell |
4,901
-418
| -8% | -$104K | 0.21% | 98 |
|
|
2020
Q2 | $1.36M | Buy |
5,319
+310
| +6% | +$70.7K | 0.29% | 76 |
|
|
2020
Q1 | $1.18M | Sell |
5,009
-2,763
| -36% | -$604K | 0.28% | 71 |
|
|
2019
Q4 | $1.85M | Buy |
7,772
+2,796
| +56% | +$616K | 0.38% | 60 |
|
|
2019
Q3 | $1.1M | Sell |
4,976
-625
| -11% | -$120K | 0.24% | 81 |
|
|
2019
Q2 | $985K | Sell |
5,601
-74
| -1% | -$13.3K | 0.23% | 86 |
|
|
2019
Q1 | $986K | Sell |
5,675
-1,286
| -18% | -$246K | 0.24% | 86 |
|
|
2018
Q4 | $1.3M | Buy |
6,961
+813
| +13% | +$159K | 0.34% | 62 |
|
|
2018
Q3 | $1.22M | Sell |
6,148
-70
| -1% | -$13.8K | 0.33% | 68 |
|
|
2018
Q2 | $1.22M | Buy |
6,218
+1,705
| +38% | +$302K | 0.33% | 71 |
|
|
2018
Q1 | $832K | Sell |
4,513
-2,089
| -32% | -$383K | 0.23% | 117 |
|
|
2017
Q4 | $1.16M | Sell |
6,602
-157
| -2% | -$27.8K | 0.33% | 76 |
|
|
2017
Q3 | $1.17M | Buy |
6,759
+993
| +17% | +$176K | 0.36% | 66 |
|
|
2017
Q2 | $1M | Hold |
5,766
| – | – | 0.32% | 74 |
|
|
2017
Q1 | $1M | Buy |
5,766
+2,741
| +91% | +$455K | 0.32% | 74 |
|
|
2016
Q4 | $539K | Buy |
3,025
+351
| +13% | +$52.8K | 0.17% | 158 |
|
|
2016
Q3 | $393K | Buy |
2,674
+89
| +3% | +$15.1K | 0.14% | 181 |
|
|
2016
Q2 | $445K | Buy |
2,585
+1,005
| +64% | +$156K | 0.16% | 160 |
|
|
2016
Q1 | $258K | Sell |
1,580
-47
| -3% | -$6.98K | 0.16% | 151 |
|
|
2015
Q4 | $254K | Buy |
+1,627
| New | +$256K | 0.17% | 156 |
|
Other funds holding AMGN
HighPoint Advisor Group's AMGN Position: Q2 2026 in Review
HighPoint Advisor Group increased its Amgen (AMGN) stake by 19% in Q2 2026, buying an estimated $157K and bringing the position to 2,946 shares worth $1.07M. The position accounts for 0.04% of the portfolio, ranked #308.
HighPoint Advisor Group first reported a position in AMGN in Q4 2015 and has held it in 36 quarters since. The position peaked at $4.68M in Q4 2025. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- HighPoint Advisor Group held 2,946 shares of Amgen worth $1.07M as of Q2 2026.
- HighPoint Advisor Group bought 460 Amgen shares in Q2 2026, an estimated $157K.
- Amgen made up 0.04% of HighPoint Advisor Group's portfolio in Q2 2026, its #308 holding.
- HighPoint Advisor Group first reported a position in Amgen in Q4 2015 and has held it in 36 quarters since.
- HighPoint Advisor Group's Amgen position peaked at $4.68M in Q4 2025.
- 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on HighPoint Advisor Group's 13F filing for Q2 2026, filed 5 Aug 2026.